Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank hikes target price on Synthomer

(Sharecast News) - Deutsche Bank raised its price target on Synthomer to 92p from 62p on Tuesday, but kept its 'hold' rating, saying trading momentum and portfolio performance continued to improve. The broker said the Synthomer's AGM update confirmed strong revenue and underlying earnings growth in the first quarter, with margins ahead of the prior year and trading accelerating through April and May. It added that Synthomer's 'in‑region for region' operating model was helping the business navigate supply‑chain volatility linked to the Iran conflict.

Deutsche Bank highlighted particularly strong delivery in the coatings and construction solutions division, which drove growth in volumes, revenue and EBITDA over the first five months of 2026. Adhesive solutions was described as stable, while HPPM saw a slower start to the year.

The German bank said the update supported its view that operational progress was continuing across the portfolio.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.